Jefferies Downgrades NewLink Genetics To Hold

Analysts at Jefferies downgraded

from Buy to Hold. The price target for NewLink Genetics is set to $50. NewLink Genetics shares have gained 115.93% over the past 52 weeks, while the S&P 500 index has surged 9.05% in the same period. NewLink Genetics' shares rose 1.32% to $54.65 in after-hours trading.